Key Insights

Highlights

Treatment Research

3 treatments under study, led by Ap1903

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02792114Phase 1Active Not Recruiting

T-Cell Therapy for Advanced Breast Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Ap19031
  • Cyclophosphamide1
  • Mesothelintargeted T Cells1

Active Sponsors

  • United States Department of Defense1
  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Related Conditions

  • Breast Cancer1

Activity Timeline